Severe infantile pertussis in Nigeria, report of two cases: the need for review of current pertussis vaccination schedule
DOI:
https://doi.org/10.60787/tnhj.v19i1.424Keywords:
Bordetella, developing countries, diagnosis, infant, maternal immunization, Nigeria, pertussis, prevention, whooping coughAbstract
Title: Severe infantile pertussis in Nigeria, report of two cases: the need for review of current pertussis vaccination schedule.
Background: Pertussis, whooping cough is a highly contagious bacterial infection. Although the growing majority of cases are above 6years, 10-15% of all cases of pertussis occur in infants younger than 6 months and more than 90% of deaths occur in this age group. Vaccination against the disease in Nigeria usually occurs between 6 and 14 weeks of age, leaving these neonates and infants largely unprotected, especially when exposed before and during this period.
Case report: We present two cases; a 6 week old male infant and a 9 week old female; who presented with symptoms of severe cough, apnoeic episodes and seizures. Full blood count showed lymphocytosis and chest x-ray revealed patchy opacities in one of them. Diagnosis was made clinically and they were managed with erythromycin and azithromycin respectively as well as intensive supportive care.
Conclusion: Pertussis should be considered in any infant presenting with cough and apnoea, as it can be associated with significant morbidity and mortality requiring aggressive supportive care. The management of pertussis in developing countries urgently needs a scale up of diagnostic capacity and prevention strategies.
Downloads
References
CDC. Pertussis | Whooping cough. Aug 2017. [assessed and cited on 2018 January 4] available from URL: http://www.cdc.gov/pertussis.
WHO position paper. Pertussis vaccines. September 2015. Wkly Epidemiol Record 2015; 90:433-60.
Gabutti G, Maria C. Pertussis: A Review of Disease Epidemiology Worldwide and in Italy. Int J Environ Res Public Health 2012 Dec; 9(12): 4626-4638.
Nigeria pertussis cases, 1949-2016. [Assessed and cited on 2018 January 7]. Available from URL:https://knoema.com/atlas/Nigeria/topics/Health/Communicable-Disease/Pertussis-cases.
Pertussis: Practice Essentials, Background, Etiology and Pathophysiology. [Assessed and cited on 2018 January 10], available from: URL: http://emedicine.medscape.com/article/967268.
WHO. Vaccines and diseases: Pertussis. [Assessed and cited on 2018 January 10] Available from URL: http://www.who.int/immunization/diseases/pertussis/en/
Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J.2004 Nov; 23 (11): 985-9.
Oloyede IP, Ekanem AM, Udoh EE. Pattern of childhood pertussis in a tertiary hospital in Nigeria: a five-year review (2007-2011). Niger J Paed 2015: Vol 42 (2) 83-87.
The World Bank’s updated International Poverty Line, a case of poor measurement? April 2016. [Assessed and cited on 2018 March 8] available from: URL: www.brettonwoodsproject.org>2016/04.
Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015 Feb 1; 60 (3): 333-7.
Sobanjo-Ter Meulen A, Duclos P, Mclntyre P, et al. Assessing the evidence for maternal pertussis immunization: A Report from Bill & Melinda Gates Foundation symposium on Pertussis Infant disease burden in low and lower-middle-income countries. Clin Infect Dis 2016; 63(Suppl 4), S123-S133.
Villena R, Vidal P, Carrillo F, Salinas M. Pertussis vaccination in pregnancy: Security and effectiveness in the protection of the infant. Rev Chil Pediatr. 2017; 88 (3):318-323.
Sadoh AE, Oladokun RE. Re-emergence of diphtheria and pertussis: implications for Nigeria. Vaccine 2012 Nov 26; 30 (50): 7221-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
